SMPD1 and obesity disorder: Several lines of evidence, from in vivo mouse studies and analyses of metabolomics and lipidomics datasets from patients, support a correlation between increased levels of ceramide in tissues and in blood serum in obesity and suggest a mechanistic role played by ceramide, the main product of ASM activity, in the pathophysiology of metabolic diseases30–33.